Dr Sharadah Essapen: Clinical oncology
Search

Dr Sharadah Essapen

Clinical oncology

 

  • Fee assured
Overview

Specialises in

  • Colon
  • Gynaecology
  • Lower GI

About me

Dr Essapen was appointed as Consultant Clinical Oncologist at St Luke’s Cancer Centre (Royal Surrey County NHS Foundation Trust) in February 2003, and specialises in gastrointestinal and gynaecological cancers.
She undertook her formal Oncology training in a number of large Cancer Centres – Barts and The London NHS Trust, The Royal Marsden Hospital and the Royal Surrey County Hospital. Prior to her Consultant appointment, she undertook a two-year MD research programme that investigated whether specific proteins in colon cancer could predict prognosis.
Dr Essapen is based at The Royal Surrey County NHS Foundation Trust, but also works at St Peter’s Hospital and Frimley Park NHS Foundation Trust. She continues to play a pivotal role in improving patient care, and has previously held the post of Lead Clinician for Radiotherapy at St Luke’s Cancer Centre. She is currently Chairperson of the weekly Network Gynae-Oncology multi-disciplinary meeting, and is also a member of the Medical Advisory Committee at Mount Alvernia BMI Hospital. She was also recently invited to do some important work for the GMC.
Dr Essapen is trained in the delivery of Intensity Modulated Radiotherapy (IMRT) for anal and endometrial cancers, and Papillon therapy for rectal cancers. She plays a significant role in clinical research at St Luke’s Cancer Centre (SLCC) and is the Principal Investigator on numerous national and international colorectal, anal and gynaecological cancer trials. She is also involved in collaborative laboratory-based research investigating the prognostic role of cancer cell surface receptors, and provides regular clinical supervision to PhD researchers, and has published widely in her area of expertise.
Dr Essapen is a Trustee for two SLCC-based charities - BRIGHT (a gastrointestinal cancer charity) and GRACE (Gynae-oncology Research and Clinical Excellence). She is fully committed to supporting research and improving outcomes for her patients.

Areas of interest

Colorectal cancer; Anal cancer; Gynaecological oncology, including Ovarian cancer, endometrial cancer, vulvar and vaginal cancers

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0002

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 14 days - (>50)

    BMI Mount Alvernia Hospital (>50)

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (>50)

    BMI Mount Alvernia Hospital (5-50)

  • X0001

    Clinical supervision and planning for the delivery of chemotherapy regimens for 0 to 7 days - (5-50)

    BMI Mount Alvernia Hospital (5-50)

  • X0004

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (5-50)

    BMI Mount Alvernia Hospital (1-5)

  • X0008

    Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (5-50)

  • BT342

    Insertion and removal of a radioactive agent (brachytherapy) into cervix or other female intra-pelvic tissue - (1-5)

  • X0007

    Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)

  • X6774

    Preparation for intermediate radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)

  • Show All (11)...
Edit details Print page

The information contained on Finder is submitted by consultants, therapists and facilities, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the data and information on Finder and our website terms of use here.